| Literature DB >> 21587195 |
Alessio G Morganti1, Savino Cilla, Andrea de Gaetano, Simona Panunzi, Cinzia Digesù, Gabriella Macchia, Mariangela Massaccesi, Francesco Deodato, Gabriella Ferrandina, Numa Cellini, Giovanni Scambia, Angelo Piermattei, Vincenzo Valentini.
Abstract
The purpose was to compare the dosimetric results observed in 201 breast cancer patients submitted to tangential forward intensity-modulated radiation therapy (IMRT) with those observed in 131 patients treated with a standard wedged 3D technique for postoperative treatment of whole breast, according to breast size and supraclavicular node irradiation. Following dosimetric parameters were used for the comparison: D(max), D(min), D(mean), V(95%) and V(107%) for the irradiated volume; D(max), D(mean), V(80%) and V(95%) for the ipsilateral lung; D(max), D(mean), V(80%) and V(95%) for the heart. Stratification was made according to breast size and supraclavicular (SCV) nodal irradiation. As respect to irradiated volume, a significant reduction of V(107%) (mean values: 7.0 ± 6.6 versus 2.4 ± 3.7, p < 0.001) and D(max) (mean % values: 111.2 ± 2.7 versus 107.7 ± 6.3, p < 0.001), and an increase of D(min) (mean % values: 65.0 ± 17.4 versus 74.9 ± 12.9, p < 0.001) were observed with forward IMRT. The homogeneity of dose distribution to target volume significantly improved with forward IMRT in all patient groups, irrespective of breast size or supraclavicular nodal irradiation. When patients treated with supraclavicular nodal irradiation were excluded from the analysis, forward IMRT slightly reduced V(80%) (mean values: 3.7 ± 2.6 versus 3.0 ± 2.4, p = 0.03) and V(95%) (mean values 1.9 ± 1.8 versus 1.2%± 1.5; p = 0.001) of the ipsilateral lung. The dose to the heart tended to be lower with IMRT but this difference was not statistically significant. Tangential forward IMRT in postoperative treatment of whole breast improved dosimetric parameters in terms of homogeneity of dose distribution to the target in a large sample of patients, independent of breast size or supraclavicular nodal irradiation. Lung irradiation was slightly reduced in patients not undergoing to supraclavicular irradiation.Entities:
Mesh:
Year: 2011 PMID: 21587195 PMCID: PMC5718668 DOI: 10.1120/jacmp.v12i2.3451
Source DB: PubMed Journal: J Appl Clin Med Phys ISSN: 1526-9914 Impact factor: 2.243
Patient characteristics.
|
|
|
| |||||
|---|---|---|---|---|---|---|---|
|
|
|
|
|
|
| ||
| Total: | 131 | 39.5 | 201 | 60.5 | 332 | 100 | |
|
|
| / |
| / |
| / | |
| Cancer Site: | Right Breast | 62 | 47.3 | 51 | 51.5 | 50 | 49.0 |
| Left Breast | 69 | 52.7 | 48 | 48.5 | 52 | 51.0 | |
| TNM Stage: | I | 66 | 50.4 | 103 | 51.2 | 169 | 50.9 |
| II | 52 | 39.7 | 79 | 39.3 | 131 | 39.5 | |
| III | 13 | 9.9 | 19 | 9.4 | 32 | 9.6 | |
| Regional Node Irradiation: | Yes | 22 | 16.8 | 30 | 14.9 | 52 | 15.6 |
| No | 109 | 83.2 | 171 | 85.1 | 280 | 84.4 | |
Target coverage: dosimetric comparison between standard technique and forward‐IMRT (% value) in overall population.
|
|
| ||||||
|---|---|---|---|---|---|---|---|
|
|
|
|
|
|
|
|
|
|
| 111.2 | 2.7 | 104–117 | 107.7 | 1.5 | 104–111 |
|
|
| 65.0 | 17.4 | 4–96 | 74.9 | 12.9 | 38–94 |
|
|
| 100.7 | 1.7 | 91–102 | 100.6 | 1.1 | 98–103 | 0.512 |
|
| 97.4 | 3.8 | 70–100 | 96.9 | 6.2 | 80–100 | 0.420 |
|
| 7.0 | 6.6 | 0–44 | 2.4 | 3.7 | 0–20 |
|
Target coverage: dosimetric comparison between standard technique and forward‐IMRT (% value), with or without supraclavicular nodal irradiation.
|
|
| |||||
|---|---|---|---|---|---|---|
|
|
|
|
| |||
|
|
|
|
|
|
|
|
|
|
|
| 0.011 |
|
|
|
|
|
|
| 0.159 |
|
|
|
|
|
|
| 0.08 |
|
| 0.07 |
|
|
|
| 0.136 |
|
| 0.551 |
|
|
|
| 0.617 |
|
|
|
Target coverage: dosimetric comparison between standard technique and forward‐IMRT (% value), according to breast size.
|
|
|
| |||||||
|---|---|---|---|---|---|---|---|---|---|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 0.02 |
|
| 0.09 |
|
|
|
|
|
|
| 0.24 |
|
| 0.29 |
|
| 0.59 |
|
|
|
| 0.48 |
|
| 0.12 |
|
| 0.68 |
|
|
|
|
|
|
|
|
|
| 0.001 |
Normal tissue sparing: dosimetric comparison between standard technique and forward‐IMRT (% value) for lung and heart in overall patient population.
|
|
| ||||
|---|---|---|---|---|---|
|
|
|
|
|
|
|
|
| 99.9 | 11.6 | 97.6 | 10.8 | 0.059 |
|
| 9.8 | 6 | 9.1 | 6.2 | 0.273 |
|
| 4.6 | 3.8 | 4.3 | 4.5 | 0.621 |
|
| 2.5 | 2.4 | 2.4 | 7.2 | 0.855 |
|
| 63.0 | 33.0 | 57.6 | 34 | 0.359 |
|
| 3.6 | 3.3 | 3.4 | 2.3 | 0.648 |
|
| 0.8 | 3.1 | 0.3 | 0.8 | 0.100 |
|
| 0.2 | 0.8 | 0.1 | 0.3 | 0.163 |
Analysis on 169 left breast cancer patients
Normal tissue sparing: dosimetric comparison between standard technique and forward‐IMRT (% value) for lung and heart, with or without prophylactic nodal irradiation.
|
|
|
|
|
|
|
|
|---|---|---|---|---|---|---|
|
|
|
| 0.104 |
|
| 0.069 |
|
|
|
| 0.066 |
|
| 0.626 |
|
|
|
| 0.034 |
|
| 0.080 |
|
|
|
| 0.001 |
|
| 0.227 |
|
|
|
| 0.612 |
|
| 0.418 |
|
|
|
| 0.699 |
|
| 0.547 |
|
|
|
| 0.622 |
|
| 0.310 |
|
|
|
| 0.547 |
|
| 0.212 |
Analysis on 169 left breast cancer patients
Normal tissue sparing: dosimetric comparison between standard technique and forward‐IMRT (% value) for lung (cases with supraclavicular irradiation were not included in the analysis) and heart, according to breast size.
|
|
|
| |||||||
|---|---|---|---|---|---|---|---|---|---|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 0.01 |
|
| 0.94 |
|
| 0.42 |
|
|
|
| 0.09 |
|
| 0.72 |
|
| 0.02 |
|
|
|
| 0.07 |
|
| 0.55 |
|
| 0.13 |
|
|
|
| 0.009 |
|
| 0.96 |
|
| 0.001 |
|
|
|
| 0.29 |
|
| 66.5 |
|
| 60.2 0.23 |
|
|
|
| 0.67 |
|
| 0.67 |
|
| 0.59 |
|
|
|
| 0.41 |
|
| 0.31 |
|
| 0.78 |
|
|
|
| 0.49 |
|
| 0.30 |
|
| 0.39 |
Analysis on 169 left breast cancer patients